Insulet partners with Calm for mindfulness
Analysis based on 6 articles · First reported Jul 14, 2026 · Last updated Jul 14, 2026
The partnership is unlikely to have a significant direct impact on Insulet's stock price, as it is a marketing and brand-building initiative rather than a product launch or revenue driver. However, it may enhance Insulet's brand perception and customer loyalty in the diabetes community, potentially supporting long-term growth.
Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod brand, announced a global partnership with Calm, a leading consumer mental health company, to provide emotional well-being resources for people living with diabetes, their caregivers, and healthcare professionals. The partnership launches Calm's first-ever integrated content partnership with a MedTech company, introducing The Mind in Range Collection, which includes short meditations, a breathing exercise, and a new Calm Sleep Story narrated by Lila Moss, a fashion model and Omnipod user living with type 1 diabetes. The collection is free to access on the Calm app and website. This initiative is based on Insulet's global research showing that nearly 80% of people with diabetes suffer burnout and that mental health needs are often overlooked. The partnership aims to normalize conversations around well-being and mental health in diabetes care.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard